Breaking News Headlines Today | Ground News

See every side of every news story

Wegovy image

News about Wegovy

Stay current with all the latest and breaking news about Wegovy, compare headlines and perspectives between news sources on stories happening today. In total, 141stories have been published about Wegovy which Ground News has aggregated in the past 3 months.

Covered Most By

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Wegovy News

Obesity drug prices are dropping, but getting a steady supply remains a challenge

Health · Calgary

Obesity drug prices are dropping, but getting a steady supply remains a challenge

77% Center coverage: 80 sources

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

84% Center coverage: 32 sources

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s what to know See the Story

Ozempic in a pill? The next generation of weight-loss drugs emerges

Ozempic in a pill? The next generation of weight-loss drugs emerges

50% Right coverage: 8 sources

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos lighter, she’s laughing.See the Story

Novo Nordisk Says WeightWatchers Will Sell Wegovy, Announces US$299 Price

60% Center coverage: 5 sources

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.Wegovy See the Story

Tackling Obesity Could Save Country Billions (New Zealand Government)

75% Left coverage: 4 sources

) Associate Health Minister David Seymour says the Government is delivering on its promise to give Kiwis access to more treatments, with Wegovy now available via prescription for weight loss. Medsafe made the decision to approve Wegovy in April. Stock has nowWegovy · New Zealand See the Story

Mounjaro or Wegovy? Scientists Compare Two Popular Obesity Drugs

The first major comparative study of the most talked-about weight-loss drugs in recent years shows a clear leader. Tirzepatide (known as Mounjaro) proved more effective than semaglutide (Wegovy), although both drugs clearly support patients in the fight against obesity. Photo by Rachael Ren / Unsplash Efficacy of Mounjaro and Wegovy: New data from a clinical trial Researchers from the University of Glasgow and Weill Cornell Medicine in New York …Wegovy · Poland Read Article

Swiss insurers fear cost explosion from weight loss drug

Since March 2024, Switzerland’s basic health insurance started reimbursing part of the cost of Wegovy, a weight-loss drug developed by Danish pharmaceutical giant Novo Nordisk. The decision has led to a surge in uptake—and concern among insurers, reported RTS. Roughly 40,000 people received Wegovy under Switzerland’s mandatory health insurance in 2024, according an association representing […]Wegovy · Switzerland See the Story

New Regulations for Mounjaro and Wegovy in 2025

Navigating the New Regulations: What Patients Need to Know About Accessing Mounjaro and Wegovy in 2025Regulation Read Article

The Anti-Ageing Ozempic Effect: How Weight Loss Jabs Could help...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now... anti-ageing powers?Is thereanythingthe so-called can’t do?Various studies have found that O... #health, #newshealth, #drugs, #fitnessandexercise, #longtail, #bodyshapes, #dietnutritionandweightloss, #healthwarnings, #cancerdisease, #heartdisease, #dementia, #diabetes, #flyingezeDementia See the Story

Most People Want Basic Insurance to Cover Slimming Drugs: Survey - DutchNews.nl

100% Right coverage: 2 sources

Some 90% of people in the Netherlands say Ozempic or similar types of weight loss drugs should be included in...Europe · Netherlands See the Story

This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly) @themotleyfool #stocks $UNH

100% Left coverage: 1 sources

When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments, including Mounjaro, Zepbound, Ozempic, and Wegovy. While these drugs are likely to lead to billions in revenue, Lilly and Novo aren't relying solely on these drugs to grow their businesses. Both companies are also looking into the potential that artificial …Artificial Intelligence · Minnetonka Read Article

Breaking News Topics Related to Wegovy